<DOC>
	<DOC>NCT00111891</DOC>
	<brief_summary>This is a 3-week trial in normal healthy or lipid clinic patients studying a novel approach to treating dyslipidemia.</brief_summary>
	<brief_title>An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)</brief_title>
	<detailed_description>The duration of treatment is 7 days.</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Males and females (ages 2575) A condition which, in the opinion of the investigator, might pose a risk to the patient or interfere with participating in the study</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>